LRND NYLIM U.S. Large Cap R&D Leaders ETF

Expense Ratio
0.14%
Dividend
0.31%
Previous close
$48.81
Est. 12 months change
+20.25%
Projected Price
$58.69

Profitability Metrics

Return on Equity (ROE)
70.48%
Return on Assets (ROA)
22.90%
Return on Invested Capital (ROIC)
59.20%
Weighted Average Cost of Capital (WACC)
12.05%
ROIC - WACC
47.15%
Updated : 2026-10-09 20:16 ET

Valuation Metrics

P/E Ratio
29.90
Forward P/E
25.68
PEG Ratio
1.49
Debt Current Ratio
2.57

Growth & Cash Flow

Gross Margin
65.12%
Operating Margin
40.43%
FCF Margin
27.41%
TTM Revenue Growth
47.37%
Projected 12M EPS Growth
16.43%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA20.90%
GOOGL15.06%
AAPL11.10%
MSFT9.03%
AVGO5.49%
AMZN5.42%
LLY5.41%
AMD5.30%
META5.22%
CSCO2.32%

ETF Analysis

Fund Overview

NYLIM U.S. Large Cap R&D Leaders ETF (LRND) currently reports 21 stock positions (subject to change), placing it in the concentrated range by holdings breadth. The top line-up is NVDA (20.90%), GOOGL (15.06%), AAPL (11.10%), with NVDA as the largest single weight at 20.90%. Together, the top three holdings account for 47.06%, which signals meaningful concentration at the top of the book, where a small number of names can drive outsized swings in fund performance. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 59.20%, WACC is 12.05%, and the economic spread is 47.15%. On balance, the portfolio's holdings exhibit an exceptional economic spread, compounding intrinsic value at a rate few funds can match. Supporting metrics show ROE at 70.48% and ROA at 22.90%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Turning to how the market is pricing the underlying earnings, trailing P/E of 29.90, forward P/E of 25.68, PEG of 1.49. Trailing and forward valuations are closely aligned, pointing to a market that is pricing continuity rather than improvement in the earnings outlook. A sub-1.5 PEG is a positive signal, indicating the portfolio's earnings growth expectations are more than adequate to justify current prices. The current ratio of 2.57 indicates holdings are well-positioned to meet near-term obligations. The combined picture across P/E, forward P/E, PEG, and current ratio suggests a portfolio that is priced for continued execution — where disappointment would be costly and outperformance would likely require positive earnings surprises.

Margins & Cash Generation

On the margin front: gross margin sits at 65.12%, operating margin at 40.43%, and free cash flow margin at 27.41%. At this gross margin level, the portfolio's holdings demonstrate significant pricing power and production efficiency. The operating margin here is a standout — reflecting businesses that convert a large share of gross profit into operating earnings. At this FCF margin level, the underlying holdings have considerable financial flexibility without reliance on external financing. The margin trifecta here — strong at gross, operating, and free cash flow levels — is a hallmark of competitively advantaged businesses.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 47.37% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 16.4% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

This assessment reflects quantitative metrics only and does not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.